Role of MIF and HSP70 Proteins in Immune Response for Patients Infected with Toxoplasmosis

The study was conducted on 250 suspected patients and 30 healthy persons who have visited Al-Marjan Hospital in Babil province from September 2021 to till February 2022. This study aimed to evaluation the serum levels of the MIF cytokine and HSP70 protein in females with Toxoplasmosis and control groups. The parasite was recognized after an examination of the Serum sample by using a VIDAS® TOXO IgG II. A total of 250 suspected patients were collected, all of these are females, sixty out of 250 (24 %) 60 females are patients infected with Toxoplasmosis and 30 healthy peoples. The results of current study showed higher significantly P˂0.05 in concentration MIF cytokine in patients group (45.52±21.71) ng/ml compared with control group with concentration (16.48±6.86). The concentration of HSP70 level was higher significantly P˂0.05 in patients group (3.70±3.06) ng/ml than in control group (1.61±0.92) ng/ml.